| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0021-9150(99)00346-9 |
| P698 | PubMed publication ID | 10559506 |
| P2093 | author name string | Groot PH | |
| Reape TJ | |||
| P2860 | cites work | Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity | Q72690025 |
| Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology | Q72708405 | ||
| Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells | Q73167392 | ||
| Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation | Q73701453 | ||
| Monocyte chemotactic protein-1 expression is associated with the development of vein graft intimal hyperplasia | Q73707752 | ||
| Chemokine receptor CXCR4 expression in endothelium | Q74079243 | ||
| Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines | Q74167839 | ||
| Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion | Q74351422 | ||
| Human vascular smooth muscle cells express receptors for CC chemokines | Q74351441 | ||
| Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers | Q74598515 | ||
| Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice | Q77231603 | ||
| Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages | Q77318962 | ||
| Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice | Q77340592 | ||
| Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice | Q77862249 | ||
| Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES | Q24304260 | ||
| Identification of single C motif-1/lymphotactin receptor XCR1 | Q24308835 | ||
| Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion | Q24311291 | ||
| A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells | Q24311809 | ||
| Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector | Q24312084 | ||
| Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B | Q24312103 | ||
| Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking | Q24313016 | ||
| HCC-2, a human chemokine: gene structure, expression pattern, and biological activity | Q24319555 | ||
| Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13 | Q24319684 | ||
| Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2 | Q24321318 | ||
| Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines | Q24321667 | ||
| Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7 | Q24322056 | ||
| Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response | Q24322374 | ||
| Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3 | Q24328964 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Human chemokines: an update | Q28237635 | ||
| Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant | Q28252699 | ||
| Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6 | Q28257066 | ||
| A new class of membrane-bound chemokine with a CX3C motif | Q28303204 | ||
| Mig and IP-10: CXC chemokines that target lymphocytes | Q28305342 | ||
| Assignment of the human CC chemokine gene TARC (SCYA17) to chromosome 16q13 | Q28306106 | ||
| Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice | Q28585385 | ||
| Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. | Q28590391 | ||
| Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Chemokines--chemotactic cytokines that mediate inflammation | Q29616433 | ||
| Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity | Q29617967 | ||
| Chemokines and leukocyte traffic | Q29618886 | ||
| Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions | Q30450846 | ||
| Molecular cloning and functional characterization of human MIP-1 delta, a new C-C chemokine related to mouse CCF-18 and C10. | Q32061279 | ||
| Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis | Q33613211 | ||
| Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells | Q33667974 | ||
| Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1 | Q33784182 | ||
| Monocyte chemoattractant protein-1 in human atheromatous plaques | Q34203056 | ||
| Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells | Q34229735 | ||
| T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein | Q34390132 | ||
| The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis | Q34662335 | ||
| Tumor necrosis factor-alpha in human arterial wall with atherosclerosis | Q34700760 | ||
| Chemokine production by human vascular smooth muscle cells: modulation by IL-13 | Q35026770 | ||
| Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium | Q35265510 | ||
| Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes | Q35554226 | ||
| Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils | Q35815126 | ||
| Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis | Q36028683 | ||
| Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids | Q36263522 | ||
| Multistep navigation and the combinatorial control of leukocyte chemotaxis | Q36275010 | ||
| Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin | Q36366656 | ||
| Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor | Q36380911 | ||
| Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates | Q37129086 | ||
| Activated platelets signal chemokine synthesis by human monocytes | Q37353355 | ||
| A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice | Q37377448 | ||
| Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions | Q37532544 | ||
| The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations | Q37867657 | ||
| Macrophages and angiogenesis | Q40386885 | ||
| Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy | Q40401032 | ||
| Chemokines, a family of chemotactic cytokines | Q40406074 | ||
| Chemokines, leukocyte trafficking, and inflammation | Q40502969 | ||
| Molecular properties of the chemokine receptor family | Q40527853 | ||
| Signals and signs for lymphocyte responses | Q40620206 | ||
| The interplay between primary and secondary cytokines. Cytokines involved in the regulation of monocyte recruitment | Q40910534 | ||
| Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands | Q41039459 | ||
| Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes | Q41054119 | ||
| Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines | Q41120279 | ||
| Chemokine receptors: structure, function and role in microbial pathogenesis | Q41157780 | ||
| Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene | Q41312923 | ||
| The role of chemokines in inflammation | Q41328542 | ||
| Inflammatory and immunological nature of atherosclerosis. | Q41446074 | ||
| Potential involvement of type II phospholipase A2 in atherosclerosis | Q41554170 | ||
| Cell-mediated immunity in atherosclerosis. | Q41614969 | ||
| New strategies for chemokine inhibition and modulation: you take the high road and I'll take the low road | Q41657939 | ||
| Immunological mechanisms in atherosclerosis | Q41677105 | ||
| Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma | Q42517095 | ||
| JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells | Q42823524 | ||
| Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques | Q42857233 | ||
| T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1 | Q43879904 | ||
| Interleukin-8 as a macrophage-derived mediator of angiogenesis | Q44053300 | ||
| Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. | Q46754875 | ||
| Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis | Q46897070 | ||
| EBI1-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: activated T cells strongly up-regulate CCR7 and efficiently migrate toward ELC. | Q47697986 | ||
| CD40 signaling in vascular cells: a key role in atherosclerosis? | Q47726341 | ||
| Chemokines, receptors, and their role in cardiovascular pathology | Q47743983 | ||
| The role of CXC chemokines in the regulation of angiogenesis in association with lung cancer | Q47772542 | ||
| Chemokines and the arrest of lymphocytes rolling under flow conditions. | Q52040689 | ||
| Preferential Migration of Activated CD4 + and CD8 + T Cells in Response to MIP-1α and MIP-1β | Q52062623 | ||
| Angiogenesis in abdominal aortic aneurysms. | Q52889768 | ||
| Modulation of IL-8 receptor expression on purified human T lymphocytes is associated with changed chemotactic responses to IL-8. | Q53466256 | ||
| Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. | Q54337264 | ||
| MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions | Q59064735 | ||
| Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque | Q69990504 | ||
| Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells | Q71061251 | ||
| Interleukin-8 production by macrophages from atheromatous plaques | Q71231737 | ||
| Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes | Q71671795 | ||
| Monocyte chemoattractant protein-1 gene expression in injured pig artery coincides with early appearance of infiltrating monocyte/macrophages | Q71689539 | ||
| Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells | Q72018966 | ||
| Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody | Q72080088 | ||
| Oxidized low-density lipoprotein enhances monocyte-endothelial cell binding against shear-stress-induced detachment | Q72090576 | ||
| Monocyte chemoattractant protein 1 inhibits growth of rat vascular smooth muscle cells | Q72655447 | ||
| P433 | issue | 2 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 213-225 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Chemokines and atherosclerosis | |
| P478 | volume | 147 |
| Q35063134 | 15-Lipoxygenase-1-enhanced Src-Janus kinase 2-signal transducer and activator of transcription 3 stimulation and monocyte chemoattractant protein-1 expression require redox-sensitive activation of epidermal growth factor receptor in vascular wall re |
| Q40814013 | A cofactor of tRNA synthetase, p43, is secreted to up-regulate proinflammatory genes |
| Q35245132 | A mathematical model of atherosclerosis with reverse cholesterol transport and associated risk factors |
| Q39479047 | AP-1 and NF-κB transcriptionally regulate interleukin-8 in EA.Hy926 cells under shear stress |
| Q40547110 | Acute inflammatory reactions caused by histamine via monocytes/macrophages chronically participate in the initiation and progression of atherosclerosis |
| Q48268328 | Acute stress evokes selective mobilization of T cells that differ in chemokine receptor expression: a potential pathway linking immunologic reactivity to cardiovascular disease |
| Q51031594 | Adsorption as a Contributor for Inflammatory Mediators Removal by Different Hemofiltration Membranes: A Pilot Study. |
| Q44098598 | Alteration of a macrophages inflammatory protein-related protein-2 (MRP-2) response by high fat and cholesterol diet in mice |
| Q36177122 | Alveolar macrophages lack CCR2 expression and do not migrate to CCL2 |
| Q43241675 | Angiotensin II up-regulates CX3CR1 expression in THP-1 monocytes: impact on vascular inflammation and atherogenesis. |
| Q34644504 | Antiinflammatory and immunomodulatory properties of statins |
| Q47446039 | Association between monocyte chemoattractant protein-1 and blood pressure in smokers. |
| Q37400830 | Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals |
| Q34152210 | Association between protein signals and type 2 diabetes incidence |
| Q60156193 | Association of the CCR2 chemokine receptor gene polymorphism with myocardial infarction |
| Q34752215 | Astragalus polysaccharides suppress ICAM-1 and VCAM-1 expression in TNF-α-treated human vascular endothelial cells by blocking NF-κB activation |
| Q34875099 | Beyond lipid lowering: the role of statins in vascular protection |
| Q36533649 | Biochemical markers surrogating on vascular effects of sex steroid hormones |
| Q44142467 | C-reactive protein promotes adhesion of monocytes to endothelial cells via NADPH oxidase-mediated oxidative stress |
| Q73643425 | CC chemokine receptor (CCR)2 polymorphism in Czech patients with myocardial infarction |
| Q30891436 | CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice |
| Q37259261 | CCR5 deletion protects against inflammation-associated mortality in dialysis patients |
| Q37299808 | CREB-mediated IL-6 expression is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration |
| Q36676660 | CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? |
| Q42924847 | Chemokine Lkn-1/CCL15 enhances matrix metalloproteinase-9 release from human macrophages and macrophage-derived foam cells |
| Q34572318 | Chemokine receptor CCR1 disruption in bone marrow cells enhances atherosclerotic lesion development and inflammation in mice |
| Q34672038 | Chemokine receptor CCR5: from AIDS to atherosclerosis |
| Q34912596 | Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans |
| Q36687945 | Chemokines: inflammatory mediators of atherosclerosis |
| Q74574005 | Chemokines: the link between inflammation, restenosis and atherosclerosis? |
| Q46988914 | Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters |
| Q54591387 | Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled study. |
| Q33746394 | Crosstalk between perivascular adipose tissue and blood vessels. |
| Q42284817 | Current knowledge on the mechanism of atherosclerosis and pro-atherosclerotic properties of oxysterols |
| Q58885866 | Cyclooxygenase 2, toll-like receptor 4 and interleukin 1β mRNA expression in atherosclerotic plaques of type 2 diabetic patients |
| Q37141709 | Cytokine dysregulation in chronic kidney disease: how can we treat it? |
| Q37864893 | Cytokine response of lymphocytes persistently infected with Chlamydia pneumoniae |
| Q21285000 | Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery |
| Q36016830 | Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed. |
| Q38333277 | Effect of C-reactive protein on gene expression in vascular endothelial cells |
| Q28287127 | Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors |
| Q28194573 | Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke |
| Q34512366 | Effect of storage conditions on the stability of recombinant human MCP-1/CCL2. |
| Q37326042 | Effects of chronic mild stress on the development of atherosclerosis and expression of toll-like receptor 4 signaling pathway in adolescent apolipoprotein E knockout mice |
| Q43744108 | Effects of histamine and interleukin-4 synthesized in arterial intima on phagocytosis by monocytes/macrophages in relation to atherosclerosis |
| Q46906607 | Effects of long-term pravastatin treatment on serum and urinary monocyte chemoattractant protein-1 levels and renal function in type 2 diabetic patients with normoalbuminuria |
| Q36492370 | Eggs modulate the inflammatory response to carbohydrate restricted diets in overweight men |
| Q34713240 | Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction. |
| Q26739691 | Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes? |
| Q26853624 | Erectile dysfunction in heart failure patients: a critical reappraisal |
| Q44115645 | Evaluation and comparison of 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT. |
| Q40516404 | GM-CSF activates RhoA, integrin and MMP expression in human monocytic cells |
| Q40500369 | Gene expression profile in interleukin-4-stimulated human vascular endothelial cells |
| Q34080318 | Genetic modifiers of atherosclerosis in mice |
| Q30559534 | Genetic variants in platelet factor 4 modulate inflammatory and platelet activation biomarkers |
| Q74286980 | Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction |
| Q38258044 | Glycosyltransferases, glycosylation and atherosclerosis |
| Q42788439 | HMC05, Herbal Formula, Inhibits TNF-α-Induced Inflammatory Response in Human Umbilical Vein Endothelial Cells |
| Q36482911 | Hematopoietic G-protein-coupled receptor kinase 2 deficiency decreases atherosclerotic lesion formation in LDL receptor-knockout mice |
| Q40805676 | Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-kappaB in THP-1 macrophages |
| Q40839063 | Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. |
| Q28367240 | Homocysteine stimulates the expression of monocyte chemoattractant protein-1 receptor (CCR2) in human monocytes: possible involvement of oxygen free radicals |
| Q24336647 | Human LZIP induces monocyte CC chemokine receptor 2 expression leading to enhancement of monocyte chemoattractant protein 1/CCL2-induced cell migration |
| Q90206556 | Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases |
| Q51542337 | Hydrostatic pressure and muscarinic receptors are involved in the release of inflammatory cytokines in human bladder smooth muscle cells. |
| Q44437789 | Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease |
| Q79285484 | IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced atherogenesis |
| Q92867012 | Identification and validation of four hub genes involved in the plaque deterioration of atherosclerosis |
| Q40723381 | Identification of a signal transduction switch in the chemokine receptor CXCR1. |
| Q30804314 | Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data |
| Q27472957 | Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge |
| Q35201247 | Inflammatory and thrombotic mechanisms in coronary atherosclerosis |
| Q37209762 | Inflammatory angiogenesis in atherogenesis--a double-edged sword |
| Q82953450 | Inflammatory markers in a randomised soya intervention among men |
| Q35045007 | Inhibition by pentoxifylline of TNF-alpha-stimulated fractalkine production in vascular smooth muscle cells: evidence for mediation by NF-kappa B down-regulation. |
| Q80067132 | Inhibition of migration of monocytes and granulocytes in vivo by the peptide corresponding to sequence 65-76 of monocyte chemotactic protein-1 (MCP-1) |
| Q74045131 | Inhibition of monocyte chemotactic protein-1 synthesis by statins |
| Q36376749 | Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis. |
| Q32055041 | Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes |
| Q34287120 | Interleukin-4, Oxidative Stress, Vascular Inflammation and Atherosclerosis |
| Q35007983 | Introduction. Lipid oxidation products and atherosclerosis |
| Q39634192 | Invariant natural killer T cells: linking inflammation and neovascularization in human atherosclerosis |
| Q74354815 | Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients |
| Q57635851 | Is inflammation the critical factor linking vulnerable coronary plaques to clinicalcoronary disease? |
| Q36070412 | Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis |
| Q73724962 | Long-term effect of full-mouth tooth extraction on the responsiveness of peripheral blood monocytes |
| Q53587098 | Long-term erythropoietin therapy decreases CC-chemokine levels and intima-media thickness in hemodialyzed patients. |
| Q39662004 | MKP1 Regulates the Induction of MCP1 by Streptococcus pneumoniae Pneumolysin in Human Epithelial Cells |
| Q28211059 | Macrophage inflammatory protein-1 |
| Q37394615 | Milk fat globule protein epidermal growth factor-8: a pivotal relay element within the angiotensin II and monocyte chemoattractant protein-1 signaling cascade mediating vascular smooth muscle cells invasion |
| Q35844559 | Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis |
| Q39969772 | Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes |
| Q38758037 | N-Caffeoyltryptamine, a Potent Anti-Inflammatory Phenolic Amide, Suppressed MCP-1 Expression in LPS-stimulated THP-1 Cells and Rats Fed a High-Fat Diet |
| Q38227386 | NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links |
| Q74619395 | Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosis |
| Q37502888 | Nutritional approaches and health-related properties of plant foods processed by high pressure and pulsed electric fields. |
| Q35022243 | Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients |
| Q47183992 | Opposite regulation of interleukin-8 and tumor necrosis factor-alpha by weight loss |
| Q33595857 | Palmitate induced IL-6 and MCP-1 expression in human bladder smooth muscle cells provides a link between diabetes and urinary tract infections |
| Q42789241 | Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice |
| Q28186087 | Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense |
| Q37869351 | Porphyromonas gingivalis-dendritic cell interactions: consequences for coronary artery disease |
| Q44300018 | Postprandial recruitment of neutrophils may contribute to endothelial dysfunction |
| Q84310981 | Potential involvement of CCL23 in atherosclerotic lesion formation/progression by the enhancement of chemotaxis, adhesion molecule expression, and MMP-2 release from monocytes |
| Q58905662 | Pro- and Anti-Inflammatory Cytokine Networks in Atherosclerosis |
| Q33246067 | Proteomic analysis of differential protein expression in atherosclerosis |
| Q55235313 | Radiopaque nano and polymeric materials for atherosclerosis imaging, embolization and other catheterization procedures. |
| Q33581032 | Reduction of monocyte chemoattractant protein-1 and interleukin-8 levels by ticlopidine in TNF-alpha stimulated human umbilical vein endothelial cells |
| Q37686347 | Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells |
| Q36617129 | Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells |
| Q36052977 | Remnant lipoproteins and atherosclerosis |
| Q36818981 | Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase |
| Q38121596 | Resveratrol and its metabolites modulate cytokine-mediated induction of eotaxin-1 in human pulmonary artery endothelial cells |
| Q30445672 | Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages |
| Q35541858 | Role of Monocytes in Atherogenesis |
| Q35775318 | Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease |
| Q40856670 | SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models. |
| Q35118564 | Salusin-β not salusin-α promotes vascular inflammation in ApoE-deficient mice via the I-κBα/NF-κB pathway |
| Q43077504 | Serum levels of gelatinase associated lipocalin as indicator of the inflammatory status in coronary artery disease |
| Q34894419 | Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. |
| Q54995279 | Shape Memory Polymers Containing Higher Acrylate Content Display Increased Endothelial Cell Attachment. |
| Q28565946 | Src-dependent STAT-3-mediated expression of monocyte chemoattractant protein-1 is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration |
| Q54565890 | Statins reduce macrophage inflammatory protein-1alpha expression in human activated monocytes. |
| Q37714570 | Subclinical vascular inflammation in subjects with normal weight obesity and its association with body fat: an 18 F-FDG-PET/CT study. |
| Q37459012 | Synergistic efficacy of concurrent treatment with cilostazol and probucol on the suppression of reactive oxygen species and inflammatory markers in cultured human coronary artery endothelial cells |
| Q34979088 | Systemic inflammatory response induced by particulate matter air pollution: the importance of bone-marrow stimulation |
| Q53604476 | TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease. |
| Q35118830 | The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model |
| Q48933675 | The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice |
| Q33648166 | The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer |
| Q36739272 | The cardiovascular effects of selective estrogen receptor modulators. |
| Q30308237 | The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium |
| Q36415669 | The effect of sleep apnea and insomnia on blood levels of leptin, insulin resistance, IP-10, and hydrogen sulfide in type 2 diabetic patients. |
| Q24682472 | The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo |
| Q34310926 | The role of 18F-FDG PET/CT in large-vessel vasculitis: appropriateness of current classification criteria? |
| Q50058010 | The role of artichoke leaf tincture (Cynara scolymus) in the suppression of DNA damage and atherosclerosis in rats fed an atherogenic diet. |
| Q34207434 | The role of chemokines in atherosclerosis |
| Q36737584 | The role of scaffold microarchitecture in engineering endothelial cell immunomodulation |
| Q44136540 | The use of (99m)technetium-labeled MCP-1 to assess graft coronary artery disease in rat cardiac allografts |
| Q35751030 | Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO mice |
| Q27300289 | Toll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findings |
| Q36043171 | Trait Hostility and Acute Inflammatory Responses to Stress in the Laboratory |
| Q42947534 | Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment |
| Q78818416 | Two polymorphisms in the fracalkine receptor CX3CR1 are not associated with peripheral arterial disease |
| Q28345267 | Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice |
| Q24307800 | mRNA expression and release of interleukin-8 induced by serum amyloid A in neutrophils and monocytes |
Search more.